Chemotherapy agents and radiosensitivity
How do certain chemotherapy agents make tumors more radiosensitive?
How do certain chemotherapy agents make tumors more radiosensitive?
Patients with aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Persons with non-small cell lung cancer who received definitive radiotherapy survived longer when beta-blockers were added to the mix.
Proposed reductions in radiotherapy prompted a joint reaction from ASTRO and other cancer care organizations.
The American Society of Clinical Oncology has released a nearly 100-page report detailing the year’s most significant developments in cancer.
A small study showed the safety of using gene therapy in the salivary gland to repair damage caused by radiation for head and neck cancer.
A new tumor-tracking technique delivers higher levels of radiation to moving tumors while sparing healthy tissue in lung cancer patients. This technique is moving closer to the clinic.
Spermatogonial stem cells were used to overcome male infertility, which could help prepubertal boys rendered infertile by cancer treatments.
Administering radiotherapy after prostatectomy helped nearly two-thirds of users in a recent study remain free of prostate cancer after 10 years.
This year-long study focused on the workflow of a Radiation Oncology department and found a strong correlation between implementing a Conditions Reporting System and increasingly positive responses to staff surveys that focused on the culture of safety within the department.